Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays a new revision label (v3.6.6) replacing the previous v3.6.5, reflecting a minor maintenance update to the site rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-31T16:59:51.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a backend update; no user-facing study data or page content appears to be altered.
    Difference
    0.1%
    Check dated 2026-08-10T10:41:14.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a small backend/build update to the page.
    Difference
    0.1%
    Check dated 2026-07-27T05:45:08.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page shows a new revision stamp: Revision: v3.6.3, replacing the prior v3.6.2. This indicates a minor update to the page's version or content management.
    Difference
    0.1%
    Check dated 2026-07-05T04:55:51.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the former Revision: v3.6.0. This indicates a maintenance update to the page's build while leaving study content intact.
    Difference
    0.1%
    Check dated 2026-06-28T01:33:52.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A recruitment status notice 'No longer looking for participants' was added, and new user help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') were introduced, along with a formatting adjustment to the Intervention/Treatment heading and a site revision label (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T16:57:37.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.